Involvement of thymus in amiodarone-treated autoimmune myocarditis in rats

International Journal of Cardiology

Volumn 125, Issue 1, 2008, Pages 122-129

  Zong, Zhi Ping ^a   Matsui, Shinobu ^a   Han, Jian Feng ^a   Katsuda, Shogo ^a   Fu, Michael Lx ^b  

^a KANAZAWA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Amiodarone; Cytokine; Myocarditis; Th1 Th2 balance; Thymus

Indexed keywords

AMIODARONE; CD4 ANTIGEN; CD8 ANTIGEN; INTERFERON; INTERLEUKIN 4; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFECT; FLOW CYTOMETRY; MALE; MYOCARDITIS; NONHUMAN; PERIPHERAL LYMPHOCYTE; PHENOTYPE; PRIORITY JOURNAL; RAT; THYMUS;

AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FLOW CYTOMETRY; MALE; MYOCARDITIS; MYOSINS; PHENOTYPE; RATS; THYMUS GLAND;

EID: 39749084574     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.01.070     Document Type: Article

References (39)

1. Nakamura H., Yamamura T., Umemoto S., et al. Autoimmune response in chronic ongoing myocarditis demonstrated by heterotopic cardiac transplantation in mice. Circulation 94 (1996) 3348-3354
2. Kodama M., Matsumoto Y., Fujiwara M., Masani F., Izumi T., and Shibata A. A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fraction. Clin Immunol Immunopathol 57 (1990) 250-262
3. Izumi T., Kodama M., and Shibata A. Experimental giant cell myocarditis induced by cardiac myosin immunization. Eur Heart J 12 Suppl D (1991) 166-168
4. Kodama M., Hanawa H., Saeki M., et al. Rat dilated cardiomyopathy after autoimmune giant cell myocarditis. Circ Res 75 (1994) 278-284
5. Ceredig R., Sekaly R.P., and MacDonald H.R. Differentiation in vitro of Lyt 2+ thymocytes from embryonic Lyt 2- precursors. Nature 303 (1983) 248-250
6. Prockop S.E., Palencia S., Ryan C.M., Gordon K., Gray D., and Petrie H.T. Stromal cells provide the matrix for migration of early lymphoid progenitors through the thymic cortex. J Immunol 169 (2002) 4354-4361
7. Geenen V., and Brilot F. Role of the thymus in the development of tolerance and autoimmunity towards the neuroendocrine system. Ann N Y Acad Sci 992 (2003) 186-195
8. Levinson A.I., Zheng Y., Gaulton G., et al. A new model linking intrathymic acetylcholine receptor expression and the pathogenesis of myasthenia gravis. Ann N Y Acad Sci 998 (2003) 257-265
9. Teshima T., Reddy P., Liu C., Williams D., Cooke K.R., and Ferrara J.L. Impaired thymic negative selection causes autoimmune graft-versus-host disease. Blood 102 (2003) 429-435
10. Matsui S., Zong Z.P., Han J.F., Katsuda S., Yamaguchi N., and Fu M.L. Amiodarone minimizes experimental autoimmune myocarditis in rats. Eur J Pharmacol 469 (2003) 165-173
11. Inomata T., Hanawa H., Miyanishi T., et al. Localization of porcine cardiac myosin epitopes that induce experimental autoimmune myocarditis. Circ Res 76 (1995) 726-733
12. Okura Y., Takeda K., Honda S., et al. Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats. Circ Res 82 (1998) 1035-1042
13. Wigle D.A., Pang S.C., Watson J.D., Sarda I.R., Radakovic N.N., and Flynn T.G. Chronic ethanol treatment increases the circulating plasma levels of B-type natriuretic peptide (BNP-45) in the rat. Am J Hypertens 6 (1993) 719-722
14. Kowey P.R., Levine J.H., Herre J.M., et al. Randomized, double-blind comparison of intravenous amiodarone and bretylium in the treatment of patients with recurrent, hemodynamically destabilizing ventricular tachycardia or fibrillation. The Intravenous Amiodarone Multicenter Investigators Group. Circulation 92 (1995) 3255-3263
15. Sato K., Yamazaki K., Kanaji Y., Ohnishi S., Kasanuki H., and Demura H. Amiodarone-induced thyrotoxicosis associated with thyrotropin receptor antibody. Thyroid 8 (1998) 1123-1126
16. Thorne S.A., Barnes I., Cullinan P., and Somerville J. Amiodarone-associated thyroid dysfunction: risk factors in adults with congenital heart disease. Circulation 100 (1999) 149-154
17. Handschin A.E., Lardinois D., Schneiter D., Bloch K., and Weder W. Acute amiodarone-induced pulmonary toxicity following lung resection. Respiration 70 (2003) 310-312
18. Ott M.C., Khoor A., Leventhal J.P., Paterick T.E., and Burger C.D. Pulmonary toxicity in patients receiving low-dose amiodarone. Chest 123 (2003) 646-651
19. Najjar T.A. Disposition of amiodarone in rats after single and multiple intraperitoneal doses. Eur J Drug Metab Pharmacokinet 26 (2001) 65-69
20. Heger J.J., Prystowsky E.N., and Zipes D.P. Relationship between amiodarone dosage, drug concentrations and adverse side effects. Am Heart J 106 (1983) 931-935
21. Adams P.C., Sloan P., Morley A.R., and Holt D.W. Peripheral neutrophil inclusions in amiodarone treated patients. Br J Clin Pharmacol 22 (1986) 736-738
22. Gross S.A., Bandyopadhyay S., Klaunig J.E., and Somani P. Amiodarone and desethylamiodarone toxicity in isolated hepatocytes in culture. Proc Soc Exp Biol Med 190 (1989) 163-169
23. Rosenbaum M.B., Chiale P.A., Haedo A., Lazzari J.O., and Elizari M.V. Ten years of experience with amiodarone. Am Heart J 106 (1983) 957-964
24. Kochiadakis G.E., Igoumenidis N.E., Hamilos M.I., et al. Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: amiodarone vs propafenone, both in low doses. Chest 125 (2004) 377-383
25. Hug A., Korporal M., Schroder I., et al. Thymic export function and T cell homeostasis in patients with relapsing remitting multiple sclerosis. J Immunol 171 (2003) 432-437
26. Sakaguchi N., Takahashi T., Hata H., et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426 (2003) 454-460
27. Laurie K.L., LaGruta N.L., Koch N., vanDriel I.R., and Gleeson P.A. Thymic expression of a gastritogenic epitope results in positive selection of self-reactive pathogenic T cells. J Immunol 172 (2004) 5994-6002
28. Campbell I.L., Kay T.W., Oxbrow L., and Harrison L.C. Essential role for interferon-γ and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87 (1991) 739-742
29. + cells in the pathogenesis of organ-specific autoimmune diseases. Immunol Today 16 (1995) 34-38
30. 2, and more. Immunol Today 17 (1996) 138-146
31. 2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 162 (1999) 2511-2520
32. 2 phenotype. Am J Pathol 159 (2001) 193-203
33. Eriksson U., Kurrer M.O., Sebald W., Brombacher F., and Kopf M. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J Immunol 167 (2001) 5464-5469
34. Horwitz M.S., LaCava A., Fine C., Rodriguez E., Ilic A., and Sarvetnick N. Pancreatic expression of interferon-gamma protects mice from lethal coxsackievirus B3 infection and subsequent myocarditis. Nat Med 6 (2000) 693-697
35. Suematsu N., Tsutsui H., Wen J., et al. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107 (2003) 1418-1423
36. Tanno M., Gorog D.A., Bellahcene M., Cao X., Quinlan R.A., and Marber M.S. Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation. J Mol Cell Cardiol 35 (2003) 1523-1527
37. Higuchi Y., McTiernan C.F., Frye C.B., McGowan B.S., Chan T.O., and Feldman A.M. Tumor necrosis factor receptors 1 and 2 differentially regulate survival, cardiac dysfunction, and remodeling in transgenic mice with tumor necrosis factor-alpha-induced cardiomyopathy. Circulation 109 (2004) 1892-1897
38. Ito H., Ono K., Nishio R., Sasayama S., and Matsumori A. Amiodarone inhibits interleukin 6 production and attenuates myocardial injury induced by viral myocarditis in mice. Cytokine 17 (2002) 197-202
39. Ide T., Tsutsui H., Kinugawa S., Utsumi H., and Takeshita A. Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action. Circulation 100 (1999) 690-692